DC67313 |
6-Oxohexyl 2-hexyldecanoate
|
|
DC67312 |
1-Propanethiol, 3-(diMethylaMino)-, hydrochloride
|
|
DC67311 |
1-Propanaminium, 2,3-dihydroxy-N,N,N-trimethyl-, chloride (1:1), (2R)-
|
|
DC67310 |
1,4-Piperazinediethylamine
|
|
DC67309 |
H2N(CH2)3N(tert-butoxycarbonyl)(CH2)4NH2
|
|
DC67308 |
CbzNH-PEG1-Br
|
|
DC67307 |
1-Piperazineethanamine, N-(phenylmethyl)-
|
|
DC67306 |
1-Propanethiol, 3-(dimethylamino)-, 4-methylbenzenesulfonate (1:1)
|
|
DC60798 |
6-[1-(Hexyloxy)ethoxy]hexanal(MK16 tail)
|
6-[1-(Hexyloxy)ethoxy]hexanal is the tail fragement for MK16.MK16 is a novel blood-brain barrier (BBB)-crossing lipid nanoparticle (BLNP) platform developed for efficient mRNA delivery to the central nervous system (CNS). |
DC67297 |
SM6.1 (αvβ6 ligand)
|
SM-6.1 is a small molecule delivery vehicle developed by Arrowhead, targeting αvβ6, which selectively delivers therapeutic siRNA to lung epithelial cells and mediates durable gene silencing post-inhalation. |